Zobrazeno 1 - 10
of 56
pro vyhledávání: '"C. Byatt"'
Autor:
Timothy C. Byatt, Paul Martin
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/f48d5debee8845649ac3c499cdc700d4
Publikováno v:
Croatian Journal of Fisheries, Vol 59, Iss 3, Pp 89-98 (2001)
Gilthead sea bream, maintained in a commercial scale recirculation system, were subjected to three injections (0,5 and 10 µg -1 body weight) with a by-product from the industrial production of recombinant bovine growth hormone (rbGH). Injections wer
Externí odkaz:
https://doaj.org/article/e25fe939120f46a1b2c88b55512ae9f8
Publikováno v:
Aquaculture. 209:219-232
Tilapia ( n =12 per treatment in duplicate) were subjected to two different dietary levels of lipid (∼8% and 17%) and injected doses of recombinant bovine growth hormone (2.5 and 5.0 μg rbGH g −1 body weight week −1 ). The effects of these tre
Autor:
E. Gordon Grau, Takashi Yada, Tetsuya Hirano, Thomas A. Leedom, Robert J. Collier, John C. Byatt, N.Harold Richman, Katsuhisa Uchida
Publikováno v:
Aquaculture. 207:359-380
Experiments were performed to examine the growth-promoting effects of recombinant bovine growth hormone (rbGH) in the euryhaline tilapia ( Oreochromis mossambicus ). A radioreceptor assay using a crude membrane preparation of tilapia liver revealed t
Autor:
Katsumi Aida, Robert J. Collier, John C. Byatt, E.G. Grau, Tetsuya Hirano, Takashi Yada, Shingo Kajimura, Larry G. Riley, Katsuhisa Uchida
Publikováno v:
Fish Physiology and Biochemistry. 25:221-230
We have previously reported growth-promoting effects of recombinant bovine growth hormone (rbGH) in Mozambique tilapia, Oreochromis mossambicus, after 4 weekly injections or a single injection of slow-releasing formulation (Posilac®) (Leedom et al.
Publikováno v:
Life Sciences. 65:2755-2767
Studies have shown that bovine placental lactogen (bPL) has partial somatogenic activity in vivo even though binding results clearly indicate bPL does not cause homodimerization of the bovine somatotropin receptor (bST-R). To help understand the rece
Publikováno v:
Aquaculture. 156:113-128
Experiments were undertaken to evaluate a sustained release recombinant bovine growth hormone (rbGH) formulation (Posilac®) in salmon. The investigation was divided into two parts. The first series of studies was used to establish optimal dosages an
Autor:
Arieh Gertler, Jean Djiane, N.R. Staten, Jeanne Grosclaude, John C. Byatt, Daniel Helman, Russell E. McKinnie
Publikováno v:
Endocrinology
Endocrinology, Endocrine Society, 1997, 138 (10), pp.4069-4080
Endocrinology, Endocrine Society, 1997, 138 (10), pp.4069-4080
Bovine placental lactogen (bPL) is capable of binding and transducing biological activity via somatogenic and lactogenic receptors. To modify this capability, three analogs, bPL(K73D), bPL(K73F) and bPL(K73A), mutated at position 73, and correspondin
Publikováno v:
Fish & Shellfish Immunology. 7:297-304
Size-selected (167±11 mm) female rainbow trout were: given a high (1·8 μg g−1body weight per week) or low (0·35 μg g−1) dose of recombinant bovine growth hormone (GH), delivered by cholesterol pellet implant; injected with a commercial bival
Publikováno v:
Aquaculture Nutrition. 2:243-248
The effect of recombinant bovine placenta) lactogen (rbPL) treatment upon growth of juvenile chinook salmon, Oncorhynchus tshawytscha (Walbaum) (14.0 ± 0.31 g wet wt), was examined over a period of 6 weeks. Experimental animals were either injected